Skip to content

Clinical trials

Phase 3 Hemophilia A trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hemophilia A Phase: Phase 3 Country / region: China Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20111
20121
20163
20184
20193
20202
20215
20222
20234
20242
20254
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed17
Active, not recruiting8
Recruiting8
Unknown status4
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S5
Genzyme, a Sanofi Company4
Hangzhou Gensciences Biopharmaceutical Co., Ltd.4
Pfizer4
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.3
Hoffmann-La Roche3
Sinocelltech Ltd.3
Sanofi2
Zhengzhou Gensciences Inc2
Bayer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hemophilia A38
Hemophilia B6
Blood Coagulation Disorders2
Blood Coagulation Disorders, Inherited2
Coagulation Protein Disorders2
Genetic Diseases, Inborn2
Genetic Diseases, X-Linked2
Hematologic Diseases2
Hemorrhage2
Hemorrhagic Disorders2

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.